title: Which is the appropriate hormone replacement therapy after sub-total hysterectomy?
authors.affiliation: Department of Obstetrics and Gynaecology, Farnborough Hospital, Kent, UK.
authors.forename: F
authors.initials: F
authors.lastname: Imoh-Ita
authors.forename: P
authors.initials: P
authors.lastname: Morgan
authors.forename: J
authors.initials: J
authors.lastname: Rymer
mesh_terms: D000279:Administration, Cutaneous; D004107:Dilatation and Curettage; D004715:Endometriosis / Q000601:surgery; D004958:Estradiol / Q000008:administration & dosage; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007889:Leiomyoma / Q000601:surgery; D008875:Middle Aged; D009644:Norgestrel / Q000008:administration & dosage; D010052:Ovariectomy; D011372:Progestins / Q000008:administration & dosage; D014592:Uterine Hemorrhage / Q000209:etiology; D014594:Uterine Neoplasms / Q000601:surgery
chemical_list: D004966:Estrogens, Conjugated (USP); D011372:Progestins; D009644:Norgestrel; D004958:Estradiol